Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ten model mutagens evaluated by the micronucleus test.

P Maier, W Schmid

    Mutation Research
    |November 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Altered gait stability and regularity in lower limb amputees observed across different body segments.

    Journal of biomechanics·2025
    Same author

    [Feasibility of clinical examination scenarios under pandemic conditions].

    HNO·2024
    Same author

    Ultrasound-guided caudal blockade and sedation for paediatric surgery: a retrospective cohort study.

    Anaesthesia·2022
    Same author

    [Early diagnosis of keratoconus].

    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2021
    Same author

    Toric IOL positioning with a no-touch head-up display axis alignment.

    International ophthalmology·2019
    Same author

    [Scleral melting after cyclophotocoagulation].

    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2019
    Same journal

    Monoallelic germline RAD51C, RAD51D, and BRIP1 variants in hereditary cancer testing: Variant spectrum and clinical counselling implications.

    Mutation research·2026
    Same journal

    Prediction of hepatocellular carcinoma associated biomarkers in TP53 gene; A comprehensive in silico analysis.

    Mutation research·2026
    Same journal

    IDH1 mutation promotes angiogenesis via upregulation of hypoxia inducible factor 1 alpha in glial tumors.

    Mutation research·2026
    Same journal

    Targeting overexpressed oncogenes in esophageal cancer through miRNA-mediated gene silencing: Insights from binding affinity and thermodynamic profiling.

    Mutation research·2026
    Same journal

    The active compound quercetin from Polygonum cuspidatum targets COL3A1 to enhance CD8⁺ T cell cytotoxicity in gastric cancer.

    Mutation research·2026
    Same journal

    E2F1 promotes LIHC malignant phenotype via NEK2-mediated Wnt/β-catenin and Notch activation and EMT.

    Mutation research·2026
    See all related articles

    This study evaluated ten mutagenic compounds using the mouse micronucleus bone marrow test (MNT). The MNT effectively identified various genetic damages, highlighting the importance of combining in vivo and in vitro testing for comprehensive mutagenicity assessment.

    Area of Science:

    • Toxicology
    • Genetics
    • Cell Biology

    Background:

    • Mutagenic compounds pose risks to genetic integrity.
    • Accurate assessment of mutagenicity is crucial for safety evaluations.
    • The micronucleus bone marrow test (MNT) is a standard method for detecting genotoxicity.

    Purpose of the Study:

    • To evaluate the mutagenic potential of ten different compounds using the MNT in mice.
    • To establish dose-effect relationships for each compound.
    • To compare in vivo MNT results with in vitro chromosome analyses for selected compounds.

    Main Methods:

    • Ten mutagenic compounds were tested in the mouse micronucleus bone marrow test (MNT).
    • Dose-effect curves were generated for all tested compounds.

    Related Experiment Videos

  • Chromosome aberration analyses were performed on Chinese hamster fibroblasts in vitro for several compounds.

    • Main Results:

    • The MNT identified different types of genetic damage, including chromosome breakage, rearrangements, and aneuploidy, induced by various compounds.
    • Most compounds showed effects within the therapeutic dose range.
    • Bleomycin (BM) yielded negative results in vivo, underscoring the need for combined testing approaches.

    Conclusions:

    • The MNT is a sensitive method for detecting mutagenicity and provides insights into bone marrow proliferation and cell cycle kinetics.
    • Specific mutagenic mechanisms (e.g., spindle impairment, DNA breakage) can be inferred from MNT results.
    • Integrating in vivo and in vitro assays is essential for a thorough assessment of mutagenic potential, especially when cell cycle arrest occurs.